NeuroBo Pharmaceuticals Completes Enrollment Of Part 1 Of Its Phase 2a Clinical Trial Evaluating DA-1241 For Treatment Of MASH
NeuroBo Pharmaceuticals 完成了评估 DA-1241 治疗 MASH 的 2a 期临床试验第 1 部分的注册
NeuroBo Pharmaceuticals Completes Enrollment Of Part 1 Of Its Phase 2a Clinical Trial Evaluating DA-1241 For Treatment Of MASH
NeuroBo Pharmaceuticals 完成了评估 DA-1241 治疗 MASH 的 2a 期临床试验第 1 部分的注册
使用浏览器的分享功能,分享给你的好友吧